While it's possible the company could be acquired in the near term, Diabetic Investor believes potential buyers are taking a wait and see attitude believing the situation may get worse before it gets better. These potential buyers also know that even if the company raises additional capital they can still come in and buy the company for a fraction of it what it was once worth. With over 10,000 patients, a growing market share and the leading wireless system Insulet has something to offer. The question is can they fix their current issues allowing the company and their investors the opportunity to receive full value?